Taiyi
Wang
ab,
Ming
Lu
ab,
Qunqun
Du
ab,
Xi
Yao
ab,
Peng
Zhang
ab,
Xiaonan
Chen
ab,
Weiwei
Xie
ab,
Zheng
Li
c,
Yuling
Ma
d and
Yan
Zhu
*abe
aTianjin Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. E-mail: yanzhu.harvard@iCloud.com
bResearch and Development Center of TCM, Tianjin International Joint Academy of Biotechnology & Medicine, Tianjin 300457, China
cPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
dDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK
eMolecular Cardiology Research Institute, Tufts Medical Center and Tufts University School of Medicine, Boston, MA 02111, USA
First published on 8th September 2017
Correction for ‘An integrated anti-arrhythmic target network of a Chinese medicine compound, Wenxin Keli, revealed by combined machine learning and molecular pathway analysis’ by Taiyi Wang et al., Mol. BioSyst., 2017, 13, 1018–1030.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2017 |